OF the many factors involved in the response of a malignant tumour to a chemotherapeutic agent, the ability of the agent administered to reach the cancer cell is of primary importance.
20 mg.) were removed across the diameter of the remaining half of the tumour, 9 to 10 samples being taken from each tumour. These pieces of tissue were dissolved in 1 ml. of tetra ethyl ammonium hydroxide, being left in sealed tubes, in a water bath at 600 C. for 12 hours. The concentration of labelled agent present was then determined by a liquid scintillation counter. The distance that the samples lay from the tumour edge was noted, as was their relation to the distribution of the dye. Paraffin was removed from the unstained sections and autoradiographs were prepared by covering them with Kodak AR-10 stripping film and at varying intervals of exposure from 3 to 7 weeks, the emulsions were developed and the tissues stained with Nuclear Fast Red and Alcian Blue.
RESULTS
The results obtained from the scintillation counter are shown in Tables I-IV. It was apparent that the distribution of the Lissamine Green V corresponded with the histological appearance of the tumour in that, in areas stained green, the tumour appeared to be viable whereas in those not reached by the dye, there was evidence of necrosis (Fig. 2) . However, although the concentration of 35S mustard and SH thymidine was higher in the green-stained area of the tumour, penetration still occurred in the non-stained regions.
Further, it was noticed that the maximum concentration of isotope labelled agent following injection was achieved more rapidly in the green-stained, than in the non-stained areas. With both labelled agents, 90 % of maximum concentration was achieved in 1 hour in the stained area of the tumour, whereas in the nonstained portion the concentration of agent continued to rise as the time the tumour was exposed to the agent was increased (Fig. 3) . Consequently, as the time interval between injection of the agent and the death of the animal increased, the difference in concentration of agent in stained and unstained areas became less (Fig. 3, 4) .
A fall in concentration of agent was observed as the distance between the area sampled and the edge of the tumour increased. This fall in concentration was maximum across the first few millimetres of unstained tumour (Fig. 4) . A gradient across the stained portion of tumour only occurred when the time of tumour exposure to agent was short, i.e. less than 15 minutes. (Fig. 5-8) . This established the viability of these cells since thymidine is only taken up by cells activelv synthesising deoxyribonucleic acid (DNA) (Reichard and Estborn, 1951; Friedkin et al., 1956; Hughes et al., 1958; Kisieleski et al., 1961) .
DISCUSSION
In contrast to the distribution of the dye, labelled cytotoxic agent was found in all areas of the tumour examined and it would appear that the distribution of any agent administered will depend, to some extent, upon such physical characteristics as molecular weight, structure and electrical charge. The superior penetration of 35S mustard as compared with Lissamine Green V may be related to their molecular weights of 170 and 576 respectively. Of course some low molecular weight substances become rapidly bound to protein and might then behave more like Lissamine Green V.
In the unstained, largely necrotic regions of the tumour, drug concentration begins to reach levels comparable with those reached in the stained viable areas only when exposure to the drug has continued for a long time, e.g. 25 % of the concentration present in the viable region is achieved only after 80 minutes' exposure (Fig. 4) . When this time of exposure is short, i.e. less than 15 minutes, penetration of agent corresponds closely with that of the dye. Maximum concentration of agent is achieved more rapidly in the viable areas of tumour, e.g. 90 % of maximum concentration being achieved in 1 hour (cf. Rubini et al., 1960) . These findings support the work of Shapiro and Landing (1948) who found the distribution of flourescein in sarcoma 180 in mice to be determined by the length of time after injection and the presence or absence of necrosis in the tumour.
Moving from the periphery towards the centre of the tumour, the concentration of agent becomes less and a rapid fall occurs across the first few millimetres of the unstained necrotic area. It must be remembered that the physical conditions Rowe-Jones.
VOl. XXII, NO. 1. inside the necrotic centre of this transplanted tumour which becomes vascularised with some difficulty, may not be the same as occur in the necrotic areas of spontaneous tumours. If the same situation does exist however, then the penetration of cytotoxic agent will be limited in a large tumour, especially when areas of necrosis are present. That penetration of cytotoxic drugs into these regions is important is shown by the ability of cells present in these areas to take up thymidine and therefore to synthesise DNA. When treatment of human tumours is broken off because of general toxicity, some of the surviving tumour cells may divide and provide a sufficient " background growth " ultimately to produce therapeutic failure, without the need to invoke any mechanism of resistance (Klein, 1961) . These results indicate that, in the Walker 265 tumour, penetration of cytotoxic agent is a function of tumour mass, the presence or absence of necrosis, the time of exposure to the drug and the physical characteristics of the agent used. Initial observations, which have since been made in eight different human tumours, appear to confirm the importance of these factors in determining the penetration of cytotoxic drugs and the accessibility of many cancer cells to cytotoxic drugs in large malignant tumours especially those with considerable areas of necrosis, will be limited. This will apply particularly to many alkylating agents with a short biological half-life, chosen because of their ability to produce less side effects and which, therefore, come into contact with the tumour for only a short time while in an active form. It is possible also that an antimetabolite, having a specific affinity for a particular molecule present in the viable part of a tumour but not in a largely necrotic area (e.g. methotrexate and dihydrofolate reductase), might be diverted from the latter by mass-action. However, if the molecular structure remains simple, the use of an antimetabolite which persists for a long time and would ultimately reach the necrotic part of the tumour may be indicated in preference to a rapidly inactivated alkylating agent in the treatment of a large tumour mass.
The results obtained in this study support the statement by Larionov (1959) based on clinical material that " the degree of anti tumour effect is inversely proportional to the mass of tumour tissue ".
